These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 2400993

  • 1. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
    White S, Taetle R, Seligman PA, Rutherford M, Trowbridge IS.
    Cancer Res; 1990 Oct 01; 50(19):6295-301. PubMed ID: 2400993
    [Abstract] [Full Text] [Related]

  • 2. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
    Sauvage CA, Mendelsohn JC, Lesley JF, Trowbridge IS.
    Cancer Res; 1987 Feb 01; 47(3):747-53. PubMed ID: 3802079
    [Abstract] [Full Text] [Related]

  • 3. Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells.
    Taetle R, Honeysett JM.
    Cancer Res; 1987 Apr 15; 47(8):2040-4. PubMed ID: 3828993
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H, Moroyama T, Mendelsohn J.
    Cancer Res; 1986 Nov 15; 46(11):5592-8. PubMed ID: 3756906
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.
    Taetle R, Castagnola J, Mendelsohn J.
    Cancer Res; 1986 Apr 15; 46(4 Pt 1):1759-63. PubMed ID: 3004704
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M, Bergamaschi G, Dezza L, D'Uva R, Ponchio L, Rosti V, Ascari E.
    Cancer Res; 1991 Jan 15; 51(2):536-41. PubMed ID: 1985771
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.
    Kemp JD, Cardillo T, Stewart BC, Kehrberg E, Weiner G, Hedlund B, Naumann PW.
    Cancer Res; 1995 Sep 01; 55(17):3817-24. PubMed ID: 7641199
    [Abstract] [Full Text] [Related]

  • 9. Synergistic inhibition of T-lymphoblastic leukemic CCRF-CEM cell growth by gallium and recombinant human alpha-interferon through action on cellular iron uptake.
    Chitambar CR, Wereley JP, Riaz-ul-Haq.
    Cancer Res; 1994 Jun 15; 54(12):3224-8. PubMed ID: 8205543
    [Abstract] [Full Text] [Related]

  • 10. Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.
    Brooks D, Taylor C, Dos Santos B, Linden H, Houghton A, Hecht TT, Kornfeld S, Taetle R.
    Clin Cancer Res; 1995 Nov 15; 1(11):1259-65. PubMed ID: 9815920
    [Abstract] [Full Text] [Related]

  • 11. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G.
    Cancer Chemother Pharmacol; 2002 Dec 15; 50(6):490-6. PubMed ID: 12451476
    [Abstract] [Full Text] [Related]

  • 12. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z, Masui H, Altas I, Mendelsohn J.
    Cancer Res; 1993 Sep 15; 53(18):4322-8. PubMed ID: 8364927
    [Abstract] [Full Text] [Related]

  • 13. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC, Guan Y, Soenen DR, Danishefsky SJ, Boger DL.
    Cancer Chemother Pharmacol; 2005 Oct 15; 56(4):379-90. PubMed ID: 15875185
    [Abstract] [Full Text] [Related]

  • 14. Growth and differentiation of a human T-cell leukemia cell line, CCRF-CEM, grafted in mice.
    Houghton PJ, Mirro J, Goorha RM, Raimondi SC, Fridland A, Houghton JA.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7124-31. PubMed ID: 2555061
    [Abstract] [Full Text] [Related]

  • 15. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
    Bianco C, Bianco R, Tortora G, Damiano V, Guerrieri P, Montemaggi P, Mendelsohn J, De Placido S, Bianco AR, Ciardiello F.
    Clin Cancer Res; 2000 Nov 15; 6(11):4343-50. PubMed ID: 11106252
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.
    Fan Z, Baselga J, Masui H, Mendelsohn J.
    Cancer Res; 1993 Oct 01; 53(19):4637-42. PubMed ID: 8402640
    [Abstract] [Full Text] [Related]

  • 17. Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
    Perera RM, Narita Y, Furnari FB, Gan HK, Murone C, Ahlkvist M, Luwor RB, Burgess AW, Stockert E, Jungbluth AA, Old LJ, Cavenee WK, Scott AM, Johns TG.
    Clin Cancer Res; 2005 Sep 01; 11(17):6390-9. PubMed ID: 16144944
    [Abstract] [Full Text] [Related]

  • 18. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
    Crépin R, Goenaga AL, Jullienne B, Bougherara H, Legay C, Benihoud K, Marks JD, Poul MA.
    Cancer Res; 2010 Jul 01; 70(13):5497-506. PubMed ID: 20530676
    [Abstract] [Full Text] [Related]

  • 19. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin DJ.
    Cancer Res; 1999 Oct 15; 59(20):5209-18. PubMed ID: 10537299
    [Abstract] [Full Text] [Related]

  • 20. Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate.
    Jones DT, Trowbridge IS, Harris AL.
    Cancer Res; 2006 Mar 01; 66(5):2749-56. PubMed ID: 16510596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.